skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Local gene delivery via endovascular stents coated with dodecylated chitosan–plasmid DNA nanoparticles

Original Research

(1824) Views  (735) Full article downloads

Authors: Dunwan Zhu, Xu Jin, Xigang Leng, et al

Published Date December 2010 Volume 2010:5 Pages 1095 - 1102
DOI: http://dx.doi.org/10.2147/IJN.S14358

Dunwan Zhu1*, Xu Jin2*, Xigang Leng1, Hai Wang1, Junbo Bao1, Wenguang Liu3, Kangde Yao3, Cunxian Song1
1Tianjin Key Laboratory of Biomedical Materials, Institute of Biomedical Engineering, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China; 2Department of Anesthesia and Pain Therapy, Capital Medical University Affiliated Beijing Tiantan Hospital, Beijing, China; 3Research Institute of Polymeric Materials, Tianjin University, Tianjin, China; *Both investigators contributed equally to this work and are senior authors.

Abstract: Development of efficacious therapeutic strategies to prevent and inhibit the occurrences of restenosis after percutaneous transluminal coronary angioplasty is critical for the treatment of cardiovascular diseases. In this study, the feasibility and efficiency of stents coated with dodecylated chitosan–plasmid DNA nanoparticles (DCDNPs) were evaluated as scaffolds for localized and prolonged delivery of reporter genes into the diseased blood vessel wall. Dodecylated chitosan–plasmid DNA complexes formed stable positive charged nanospheres with mean diameter of approximately 90–180 nm and zeta potential of +28 ± 3 mV. As prepared DCDNPs were spray-coated on stents, a thin layer of dense DCDNPs was successfully distributed onto the metal struts of the endovascular stents as demonstrated by scanning electron microscopy. The DCDNP stents were characterized for the release kinetics of plasmid DNA, and further evaluated for gene delivery and expression both in vitro and in vivo. In cell culture, DCDNP stents containing plasmid EGFP-C1 exhibited high level of GFP expression in cells grown on the stent surface and along the adjacent area. In animal studies, reporter gene activity was observed in the region of the artery in contact with the DCDNP stents, but not in adjacent arterial segments or distal organs. The DCDNP stent provides a very promising strategy for cardiovascular gene therapy.

Keywords: gene delivery, endovascular stent, chitosan, gene nanoparticles






Readers of this article also read:

Chitosan and lactic acid-grafted chitosan nanoparticles as carriers for prolonged drug delivery
Synthesis of silver/montmorillonite nanocomposites using γ-irradiation
Biocompatibility of Fe3O4/DNR magnetic nanoparticles in the treatment of hematologic malignancies
Visualization of interaction between inorganic nanoparticles and bacteria or fungi
Andrographolide nanoparticles in leishmaniasis: characterization and in vitro evaluations
A novel method for synthesizing PEGylated chitosan nanoparticles: strategy, preparation, and in vitro analysis
Supramolecular micellar nanoaggregates based on a novel chitosan/vitamin E succinate copolymer for paclitaxel selective delivery
Nanostructured model implants for in vivo studies: influence of well-defined nanotopography on de novo bone formation on titanium implants
Public optimism towards nanomedicine
Elucidation mechanism of different biological responses to multi-walled carbon nanotubes using four cell lines